The HESI Cardiac Safety Committee, alongside academic and industry collaborators, has published a new review article addressing the critical role of sodium channel Nav1.5 in cardiac safety assessments and provides guidance for identifying and mitigating proarrhythmic risks in drug development.
An Overview of Drug-Induced Sodium Channel Blockade and Changes in Cardiac Conduction: Implications for Drug Safety
Clinical and Translational Science, 2024